UT Health San Antonio's Collaborative Research Program Unites Experts to Revolutionize Cancer Treatment
December 19, 2025
December 19, 2025
SAN ANTONIO, Texas, Dec. 19 -- The University of Texas Health San Antonio issued the following news release:
* * *
UT Health San Antonio's collaborative research program unites experts to revolutionize cancer treatment
More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominan . . .
* * *
UT Health San Antonio's collaborative research program unites experts to revolutionize cancer treatment
More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominan . . .